Xarelto receives complete response letter

FDA has issued a second complete response letter regarding a supplemental New Drug Application (sNDA) for rivaroxaban (Xarelto, Janssen) for the reduction of the risk of cardiovascular events in patients with acute coronary syndrome (ACS).
» Full article

Colon cancer screening with EHRs

Centralized systems are likely to be the most efficient way to increase colorectal cancer screening, according to a trial published in the March 5 Annals of Internal Medicine. » Full article

Extending dabigatran use and VTE

Dabigatran used beyond the initial 3 months of treatment at a dose of 150 mg twice daily reduced the risk of recurrent venous thromboembolism, according to a study published February 21 in the New England Journal of Medicine. » Full article

Costs barriers to HIV testing

Proposed HIV-testing guidelines by the U.S. Preventive Services Task Force will remove financial barriers to routine HIV screening by eliminating out-of-pocket costs, according to a perspective article in the March 7 issue of the New England Journal of Medicine. » Full article

CONTINUING EDUCATION

New CPE Series: February activity available now

Welcome to the sixth activity in our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The February activity covers psychosocial considerations in the management of diabetes.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Prenatal vitamins- A review of the literature on benefits and risks of various nutrient supplements

Most pregnant women take a daily prenatal vitamin, but advising the patient can be difficult because so many different formulations are available. » Full article

• Rivaroxaban for DVT, PE

• CPOE systems reduce drug errors

• FDA: Pradaxa bleeding no higher than warfarin

• New combination tablet for HIV

RESOURCES

Drug Watch

Latest Clinical News

SURVEY

Do you believe the proposed sequester will have significant implications on public health drug coverage or R&D?

– Yes
– No

Respond Here
See what your colleagues are saying!

What can Formulary do for you?

Take our super short survey TODAY! http://www.surveygizmo.com/s3/1050662/Formulary-Readers